Académique Documents
Professionnel Documents
Culture Documents
Sherif El-Sarky
Professor of Surgery, Faculty of Medicine, Cairo University (Kasr Al-Ainy)
Sherif El-Sarky
Diagnostic challenges
1) 2) 3) 4) 5) Vascularity and viability of foot tissues. Extent of bony affection. Localization of deep collections. Decision for intervention. Assessment of progress.
Objectives
Disease control
1) Infection eradication. 2) Dead tissue extirpation. 3) Healing promoting.
Limb salvage
1) Anatomical integrity. 2) Function.
Strategies
1) Precise initial evaluation, for: foot vascularity, extent of infection and tissue viability.
Initial evaluation
Diagnostic challenges
1) 2) 3) 4) Vascularity and viability of foot tissues. Extent of bony affection. Localization of deep collections. Assessment of progress.
Foot vascularity is assessed by: 1) Clinical evaluation. 2) Doppler study and Duplex scan for any major vascular insufficiency above the ankle. 3) MRA for vascularity below the ankle (when suspected to be compromised).
Extent of infection is assessed by: 1) Clinical evaluation (differential pressure). 2) Bacteriological study (C&S). 3) Imaging for deep collections: contrast study (sinography) and MRI. 4) Osteomyelitis is detected by: probing test, plain X-ray and MRI.
Therapeutic Decision
Facts
1. Pedal infections occur in up to 25% of diabetic patients (Lipsky et al, 1990). 2. They are the most common cause of hospital admission in diabetics (Eckman et al, 1995). 3. Diabetic foot is behind25% of total expenses of hospital treatment in diabetics (Stiegler, 1989). 4. It is the most common cause of amputation (after trauma) in USA (Newman et al, 1991).
Facts !
The Principle
Principle
Bier's principle (direct administration of agents to tissues by retrograde venous perfusion with arterial blockade) was introduced in 1908. Since then, it was limited to regional anesthesia (local intravenous anesthesia). Eighty years later (1988), it was re-discovered as a potential approach for therapy in foot disorders, by the Latin American investigators Acevedo and Schoop from Chile.
RVP results in high tissue concentration of administered drugs. RVP results in high tissue concentration of
administered drugs.
Tissue concentration of 99 mTc labelled human 1. Tissue concentration of 99 mTc labelled human serum albumin after was: :RVP serum albumin after RVP was: .3. times higher than after intra-arterial 3 times higher than after intra-arterial . 7 times higher after systemic i.v. injection . 7 times higher thanthan after systemic i.v. injection
Pharmacologically, tissue concentration of 2. Pharmacologically, tissue concentration Netilmycin after RVP was 2.5 times higherof than 2.5 times higher than after systemic i.v.i.v. injection (Seidel et al, 1995). after systemic
Cefotaxime
once
once
Netilmycin combinatio n
daily
10 days
DNPU
daily
10 days
number
A B C D E
8 4 3 4 5
Method
Method Technic
1. 1. A A dorsal dorsal foot foot vein, vein, or or a a vein vein in in the the lower lower leg leg is is punctured. punctured. 2. veins. 2. The The leg leg is is elevated elevated for for 5 5 minutes minutes to to empty empty veins. 3. 3. A A sphygmomanometer sphygmomanometer cuff cuff is is applied applied to to the the lower lowerthigh thigh and and inflated, inflated, while while elevated, elevated, to to a a level level higher higherthan than systolic systolic pressure pressure of of the the patient. patient. 4. 4. The The agent(s) agent(s) employed employed is is slowly slowly injected injected into into the thevein vein diluted diluted in in 120 120 ml ml of of saline. saline. 5. 5. After After 20 20 minutes, minutes, the the pressure pressure is is released. released.
Clip 1
Clip 2 Clip 3
Agents Agents
group agent(s)
antibiotic (Gentamycin or otherwise) DSE/G/H/X DSE/G/H/X DSE/G/X/P DSE/PGE/G/X
A B C D E
Frequency
Frequency
group frequency
once to 3 times 3 / week 3 / week 3 / week 3 / week
A B C D E
Value of RVP
Good when arterial perfusion to the limb is inadequate...
as systemic therapy is not expected to reach therapeutic level in the target tissue.
Value of RVP
Good when a wound or an ulcer is the target
as the concentration of the therapeutic agents in wounds and ulcers reaches 3 times higher than intact skin. the "rinsing effect"
Value of RVP
Good for diabetics in particular
as it is associated with improvement in the impaired microcirculation of skin in these patients.
Value of RVP
Good when the agent is toxic
as smaller doses are required to reach the same therapeutic concentration in target tissue, and blood level after fixation in tissue is less than following systemic injection.
Value of RVP
Good when the agent is given systemically by infusion and the patient is cardiac
as this avoids volume overload hazards.
Value of RVP
Good when the agent is either expensive or not always available
as smaller doses and shorter courses are required.
Value of RVP
Good when surgery: has failed, is contraindicated or is required locally
as it can be considered as an alternative or adjunctive therapy
Value of RVP
Good Good when when time time is is a a critical critical factor factor
as as it it can can be be used used as as a a temporizing temporizing therapy therapy for for rapidly rapidly progressing progressing lesions lesions due due to to its its rapid rapid effects. effects.
Value of RVP
Good for patients patient with poor compliance to long-term therapy
10
Value of RVP